magnolol has been researched along with Eye Cancer, Retinoblastoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, YC; Chen, IL; Chen, YH; Hsieh, CC; Huang, CY; Kuo, CW; Kuo, HF; Lai, YH; Lee, PY; Lee, TY; Li, CY; Liu, CC; Liu, PL; Liu, WL; Liu, YR; Lo, J; Wang, SC; Wu, SH | 1 |
1 other study(ies) available for magnolol and Eye Cancer, Retinoblastoma
| Article | Year |
|---|---|
Magnolol regulates miR-200c-3p to inhibit epithelial-mesenchymal transition and retinoblastoma progression by modulating the ZEB1/E-cadherin axis in vitro and in vivo.
Topics: Animals; Cadherins; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; MicroRNAs; Retinal Neoplasms; Retinoblastoma; Zinc Finger E-box-Binding Homeobox 1 | 2023 |